Obesity Featured Articles

  1. Transparency In Action: The Key To Trust And Efficiency 5/8/2026

    Trust is the backbone of clinical research. Learn how you can utilize transparency and data integrity to protect participants, meet regulatory standards, and drive medical innovation.

  2. Adaptive Clinical Trials: Innovation With Hidden Challenges 5/8/2026

    Adaptive trial designs offer faster results and better patient care, but only if site infrastructure can keep up with the operational complexity of these highly flexible research models.

  3. How Remote Monitoring Is Transforming Compliance 5/8/2026

    Discover how remote monitoring is transforming pharmacy compliance. Shift from manual, onsite burdens to digital workflows that ensure real-time accuracy and continuous audit readiness.

  4. CDA Strategies That Unclog The Study Startup Bottleneck 5/8/2026

    Confidential disclosure agreements (CDAs) can cause clinical trial delays, but streamlining negotiations reduces friction and improves efficiency, fostering better long-term relationships between sponsors and sites.

  5. Collaboration Isn't Sexy. That's Kind of the Point. 5/8/2026

    SCRS’s Collaborate Forward playbook isn’t about reinventing clinical trials; it’s about fixing how people work together. Based on real-world examples, the initiative shows how small, practical changes in collaboration are already improving study startup, site relationships, and operational performance.

  6. Small Biotech Survival: Navigating Risk And Capital Scarcity With AI 5/8/2026

    Maxine Opperman discusses the challenge and the necessity of small biotech's using AI, citing its pros, cons, and strategies for use.

  7. 5 Critical Risks With The FDA's Real-Time Trial Monitoring 5/8/2026

    Life science legal experts Kimberly Chew and Odette Hauke cover the FDA proof-of-concept real-time clinical trials (RTCTs) and expose five major issues that must be addressed before the pilot expands.

  8. Executive Order For Psychedelics 5/8/2026

    We caught up with Joseph Tucker, Ph.D., CEO of Enveric Biosciences, to discuss the executive order for psychedelics.

  9. Aligning AI Use Clinical Trials With FDA And EMA Expectations 5/7/2026

    For any trial conducted in the EU/EEA, regulators want to know that AI used across clinical trial planning, conduct, and analysis is transparent, controlled, and fit for purpose. Jessica Cordes explains how even U.S.-based teams must meet EMA expectations.

  10. Optimizing Data Capture From Protocol Design To Efficacy Endpoints 5/6/2026

    The shift to digital trials favors the 11-point NRS over the traditional VAS to reduce data noise, improve elderly patient compliance, and ensure statistical power across mobile devices.